Literature DB >> 11181732

Ultrastructural localization of vesicle-associated membrane protein(s) to specialized membrane structures in human pericytes, vascular smooth muscle cells, endothelial cells, neutrophils, and eosinophils.

D Feng1, R Flaumenhaft, C Bandeira-Melo, P Weller, A Dvorak.   

Abstract

Vesicle-associated membrane proteins (VAMPs) are important to the trafficking of vesicles between membrane-bound intracytoplasmic organelles, in the facilitation of neurosecretion, and in constitutive and regulated secretion in non-neuronal cells. We used a pre-embedding ultrastructural immunonanogold method to localize VAMPs to subcellular sites in human cells of five lineages known to have cytoplasmic vesicles that may function in vesicular transport. We found VAMPs localized to caveolae in pericytes, vascular smooth muscle cells, and endothelial cells of venules, to the vesiculo-vacuolar organelle, recently defined in venular endothelial cells, to the vesicle-rich intergranular cytoplasm and secretory granule membranes of neutrophils, and to perigranular cytoplasmic secretory vesicles and secretory granule membranes in eosinophils. These specific localizations in five human vascular and granulocyte lineages support the notion that VAMPs have vesicle-associated functions in these cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181732     DOI: 10.1177/002215540104900303

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  13 in total

Review 1.  Mechanisms of eosinophil cytokine release.

Authors:  Christianne Bandeira-Melo; Peter F Weller
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-06-14       Impact factor: 2.743

2.  VAMP-7 links granule exocytosis to actin reorganization during platelet activation.

Authors:  Secil Koseoglu; Christian G Peters; Jennifer L Fitch-Tewfik; Omozuanvbo Aisiku; Lydia Danglot; Thierry Galli; Robert Flaumenhaft
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

3.  Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils.

Authors:  Rossana C N Melo; Sandra A C Perez; Lisa A Spencer; Ann M Dvorak; Peter F Weller
Journal:  Traffic       Date:  2005-10       Impact factor: 6.215

4.  SNARE-mediated rapid lysosome fusion in membrane raft clustering and dysfunction of bovine coronary arterial endothelium.

Authors:  Wei-Qing Han; Min Xia; Chun Zhang; Fan Zhang; Ming Xu; Ning-Jun Li; Pin-Lan Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-16       Impact factor: 4.733

5.  Expression and subcellular localization of the Qa-SNARE syntaxin17 in human eosinophils.

Authors:  Lívia A S Carmo; Felipe F Dias; Kássia K Malta; Kátia B Amaral; Revital Shamri; Peter F Weller; Rossana C N Melo
Journal:  Exp Cell Res       Date:  2015-08-06       Impact factor: 3.905

6.  Rat meningeal and brain microvasculature pericytes co-express the vesicular glutamate transporters 2 and 3.

Authors:  Brian N Mathur; Ariel Y Deutch
Journal:  Neurosci Lett       Date:  2008-02-16       Impact factor: 3.046

7.  SNAP-23 and syntaxin-2 localize to the extracellular surface of the platelet plasma membrane.

Authors:  Robert Flaumenhaft; Nataliya Rozenvayn; Dian Feng; Ann M Dvorak
Journal:  Blood       Date:  2007-05-07       Impact factor: 22.113

Review 8.  Eosinophil-derived cytokines in health and disease: unraveling novel mechanisms of selective secretion.

Authors:  R C N Melo; L Liu; J J Xenakis; L A Spencer
Journal:  Allergy       Date:  2013-01-25       Impact factor: 13.146

9.  Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion.

Authors:  Lisa A Spencer; Rossana C N Melo; Sandra A C Perez; Staci P Bafford; Ann M Dvorak; Peter F Weller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

10.  Vesicle-mediated secretion of human eosinophil granule-derived major basic protein.

Authors:  Rossana C N Melo; Lisa A Spencer; Sandra A C Perez; Josiane S Neves; Staci P Bafford; Ellen S Morgan; Ann M Dvorak; Peter F Weller
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.